vs

Side-by-side financial comparison of GoHealth, Inc. (GOCO) and PRO DEX INC (PDEX). Click either name above to swap in a different company.

PRO DEX INC is the larger business by last-quarter revenue ($18.7M vs $12.6M, roughly 1.5× GoHealth, Inc.). On growth, PRO DEX INC posted the faster year-over-year revenue change (11.1% vs -96.8%). PRO DEX INC produced more free cash flow last quarter ($3.5M vs $-130.2M). Over the past eight quarters, PRO DEX INC's revenue compounded faster (14.3% CAGR vs -73.9%).

GoHealth, Inc. is an American marketplace for Medicare plans including Medicare Advantage, MediGap and Medicare Part D, which are programs administered through private health insurance companies. It also operates an online health insurance marketplace offering individual health insurance and short-term health insurance.

Pro Dex Inc is a precision manufacturing enterprise that produces custom machined components, subassemblies and finished products primarily for medical device original equipment manufacturers, as well as clients in the aerospace and industrial sectors, with its core operating market covering North America.

GOCO vs PDEX — Head-to-Head

Bigger by revenue
PDEX
PDEX
1.5× larger
PDEX
$18.7M
$12.6M
GOCO
Growing faster (revenue YoY)
PDEX
PDEX
+107.9% gap
PDEX
11.1%
-96.8%
GOCO
More free cash flow
PDEX
PDEX
$133.7M more FCF
PDEX
$3.5M
$-130.2M
GOCO
Faster 2-yr revenue CAGR
PDEX
PDEX
Annualised
PDEX
14.3%
-73.9%
GOCO

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
GOCO
GOCO
PDEX
PDEX
Revenue
$12.6M
$18.7M
Net Profit
$2.2M
Gross Margin
65.6%
30.8%
Operating Margin
17.5%
Net Margin
11.7%
Revenue YoY
-96.8%
11.1%
Net Profit YoY
-227.8%
7.2%
EPS (diluted)
$0.66

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GOCO
GOCO
PDEX
PDEX
Q4 25
$12.6M
$18.7M
Q3 25
$34.2M
$18.5M
Q2 25
$94.0M
$17.5M
Q1 25
$221.0M
$17.4M
Q4 24
$389.1M
$16.8M
Q3 24
$118.3M
$14.9M
Q2 24
$105.9M
$15.0M
Q1 24
$185.6M
$14.3M
Net Profit
GOCO
GOCO
PDEX
PDEX
Q4 25
$2.2M
Q3 25
$-165.8M
$4.7M
Q2 25
$-54.3M
$1.2M
Q1 25
$-4.4M
$3.3M
Q4 24
$25.5M
$2.0M
Q3 24
$6.8M
$2.5M
Q2 24
$-26.0M
$1.6M
Q1 24
$-9.2M
$655.0K
Gross Margin
GOCO
GOCO
PDEX
PDEX
Q4 25
65.6%
30.8%
Q3 25
41.2%
29.0%
Q2 25
65.5%
19.9%
Q1 25
82.2%
33.3%
Q4 24
86.6%
30.2%
Q3 24
83.4%
34.6%
Q2 24
80.5%
27.2%
Q1 24
79.5%
28.0%
Operating Margin
GOCO
GOCO
PDEX
PDEX
Q4 25
17.5%
Q3 25
-842.2%
16.8%
Q2 25
-105.7%
7.7%
Q1 25
3.0%
20.9%
Q4 24
20.6%
16.0%
Q3 24
-36.1%
20.2%
Q2 24
-38.4%
15.6%
Q1 24
-2.2%
15.5%
Net Margin
GOCO
GOCO
PDEX
PDEX
Q4 25
11.7%
Q3 25
-485.1%
25.3%
Q2 25
-57.7%
6.8%
Q1 25
-2.0%
18.8%
Q4 24
6.6%
12.1%
Q3 24
5.7%
16.6%
Q2 24
-24.6%
10.6%
Q1 24
-5.0%
4.6%
EPS (diluted)
GOCO
GOCO
PDEX
PDEX
Q4 25
$0.66
Q3 25
$-11.80
$1.40
Q2 25
$-5.10
$0.33
Q1 25
$-0.52
$0.98
Q4 24
$2.62
$0.61
Q3 24
$0.46
$0.75
Q2 24
$-2.70
$0.44
Q1 24
$-1.04
$0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GOCO
GOCO
PDEX
PDEX
Cash + ST InvestmentsLiquidity on hand
$32.9M
$6.1M
Total DebtLower is stronger
$636.7M
Stockholders' EquityBook value
$37.9M
$41.6M
Total Assets
$987.4M
$62.3M
Debt / EquityLower = less leverage
16.81×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GOCO
GOCO
PDEX
PDEX
Q4 25
$32.9M
$6.1M
Q3 25
$32.1M
$10.1M
Q2 25
$35.6M
$6.8M
Q1 25
$22.2M
$5.5M
Q4 24
$40.9M
$4.7M
Q3 24
$35.5M
$7.8M
Q2 24
$14.1M
$6.8M
Q1 24
$97.8M
$7.8M
Total Debt
GOCO
GOCO
PDEX
PDEX
Q4 25
$636.7M
Q3 25
$581.8M
Q2 25
$560.0M
$15.4M
Q1 25
$485.9M
Q4 24
$487.4M
Q3 24
$481.3M
Q2 24
$453.3M
$12.0M
Q1 24
$485.3M
Stockholders' Equity
GOCO
GOCO
PDEX
PDEX
Q4 25
$37.9M
$41.6M
Q3 25
$68.2M
$41.5M
Q2 25
$191.8M
$36.6M
Q1 25
$241.6M
$35.3M
Q4 24
$241.8M
$31.8M
Q3 24
$212.0M
$30.9M
Q2 24
$202.7M
$30.9M
Q1 24
$225.9M
$30.9M
Total Assets
GOCO
GOCO
PDEX
PDEX
Q4 25
$987.4M
$62.3M
Q3 25
$1.0B
$64.3M
Q2 25
$1.3B
$61.2M
Q1 25
$1.4B
$64.3M
Q4 24
$1.5B
$60.4M
Q3 24
$1.3B
$54.3M
Q2 24
$1.3B
$52.5M
Q1 24
$1.4B
$50.5M
Debt / Equity
GOCO
GOCO
PDEX
PDEX
Q4 25
16.81×
Q3 25
8.54×
Q2 25
2.92×
0.42×
Q1 25
2.01×
Q4 24
2.02×
Q3 24
2.27×
Q2 24
2.24×
0.39×
Q1 24
2.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GOCO
GOCO
PDEX
PDEX
Operating Cash FlowLast quarter
$-121.9M
$3.6M
Free Cash FlowOCF − Capex
$-130.2M
$3.5M
FCF MarginFCF / Revenue
-1030.1%
18.8%
Capex IntensityCapex / Revenue
65.3%
0.4%
Cash ConversionOCF / Net Profit
1.63×
TTM Free Cash FlowTrailing 4 quarters
$-221.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GOCO
GOCO
PDEX
PDEX
Q4 25
$-121.9M
$3.6M
Q3 25
$-32.7M
$2.3M
Q2 25
$-37.8M
$-173.0K
Q1 25
$-12.4M
$754.0K
Q4 24
$-21.6M
$-4.2M
Q3 24
$-12.2M
$1.9M
Q2 24
$-36.5M
$1.0M
Q1 24
$12.5M
$4.1M
Free Cash Flow
GOCO
GOCO
PDEX
PDEX
Q4 25
$-130.2M
$3.5M
Q3 25
$-35.0M
$2.2M
Q2 25
$-40.6M
Q1 25
$-15.5M
$574.0K
Q4 24
$-35.3M
$-4.7M
Q3 24
$-16.5M
$1.5M
Q2 24
$-39.2M
Q1 24
$8.0M
$4.0M
FCF Margin
GOCO
GOCO
PDEX
PDEX
Q4 25
-1030.1%
18.8%
Q3 25
-102.4%
11.9%
Q2 25
-43.2%
Q1 25
-7.0%
3.3%
Q4 24
-9.1%
-27.9%
Q3 24
-13.9%
9.8%
Q2 24
-37.0%
Q1 24
4.3%
27.7%
Capex Intensity
GOCO
GOCO
PDEX
PDEX
Q4 25
65.3%
0.4%
Q3 25
6.9%
0.5%
Q2 25
3.0%
Q1 25
1.4%
1.0%
Q4 24
3.5%
3.2%
Q3 24
3.6%
2.9%
Q2 24
2.6%
Q1 24
2.5%
0.8%
Cash Conversion
GOCO
GOCO
PDEX
PDEX
Q4 25
1.63×
Q3 25
0.49×
Q2 25
-0.14×
Q1 25
0.23×
Q4 24
-0.85×
-2.03×
Q3 24
-1.80×
0.77×
Q2 24
0.66×
Q1 24
6.22×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons